HIV Infections: all 4,342 studies

Page 10 of 44. Open to participants first (242), then studies with results posted, then the rest; newest registration first within each.

• A Study of Safety, Tolerability, and Immunogenicity of the MRKAd5 Gag/Pol/Nef Vaccine in Healthy Adults (V520-016)CompletedNCT00849680Phase 1Results posted
• Clinical Study of TUTI-16 in Asymptomatic HIV-1 Infected SubjectsCompletedNCT00848211Phase 1/2Results posted
• Treatment of Acute Hepatitis C Virus in HIV Co-InfectionCompletedNCT00845676Phase 4Results posted
• Effect of Maraviroc on Endothelial Function in HIV-Infected PatientsCompletedNCT00844519Phase 3Results posted
• Effect of Raltegravir on Endothelial Function in HIV-Infected PatientsCompletedNCT00843713Phase 4Results posted
• Behavioral Intervention to Reduce Sexual and Injection Risks Among Female Sex Workers Who Also Inject Drugs in MexicoCompletedNCT00840658Phase 2Results posted
• A Study to Determine the Antiviral Activity of TMC310911 When Administered With Ritonavir in Treatment-Naive Human Immunodeficiency Virus - Type 1 (HIV-1) Infected PatientsCompletedNCT00838162Phase 2Results posted
• Drug Interactions Between Voriconazole and Atazanavir Coadministered as Atazanavir/Ritonavir in Healthy ParticipantsCompletedNCT00833482Phase 1Results posted
• A Pilot Study Of A Novel Treatment Regimen, Maraviroc + Ritonavir Boosted Atazanavir, In Treatment Naive HIV-Infected PatientsCompletedNCT00827112Phase 2Results posted
• Chloroquine for Reducing Immune Activation in HIV- Infected IndividualsCompletedNCT00819390Phase 2Results posted
• Switching Nevirapine Immediate Release( IR) Based Regimen to Nevirapine Extended Release (XR) Based Regimen in Human Immunodeficiency Virus One (HIV-1) Infected PatientsCompletedNCT00819052Phase 3Results posted
• Pilot Study of a Raltegravir Based NRTI Sparing RegimenCompletedNCT00814879Not applicableResults posted
• Comparative Study of Three NNRTI-Sparing HAART RegimensCompletedNCT00811954Phase 3Results posted
• Safety And Efficacy Of Rifabutin In HIV PatientsCompletedNCT00810446Results posted
• Lopinavir/Ritonavir (Kaletra) PK in ChildrenCompletedNCT00810108Phase 4Results posted
• A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young AdultsTerminatedNCT00798265Phase 1Results posted
• Human Immunodeficiency Virus (HIV), Arterial Dysfunction, Lipids, Lovaza (HALO) TrialCompletedNCT00795717Phase 4Results posted
• An Open Label Pharmacokinetic, Safety And Efficacy Study Of Maraviroc In Combination With Background Therapy For The Treatment Of HIV-1 Infected, CCR5 -Tropic ChildrenStatus unknownNCT00791700Phase 2Results posted
• Aspirin and Antiretroviral Therapy in HIV Infected PatientsTerminatedNCT00783614Phase 2Results posted
• Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV DiseaseTerminatedNCT00775606Phase 4Results posted
• Antiretroviral Therapy Intensification With Raltegravir or Addition of Hyper-immune Bovine Colostrum in HIV-1 Infected Patients With Suboptimal CD4+ T Cell ResponseCompletedNCT00772590Phase 4Results posted
• Safety and Immune Response to Vicriviroc in Combination Regimens in HIV-Infected ART Experienced Children and AdolescentsCompletedNCT00766597Phase 1/2Results posted
• A Study of Raltegravir in a Diverse Cohort of HIV-Infected Patients (0518-055)CompletedNCT00764946Phase 3Results posted
• Raltegravir vs. Atazanavir in Combination With Truvada® for the Treatment of Antiretroviral naïve HIV Infected PatientsCompletedNCT00762892Phase 4Results posted
• Comparison of Liquid Kaletra and Low Dose Kaletra TabletsCompletedNCT00762320Not applicableResults posted
• Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/rCompletedNCT00756730Phase 4Results posted
• Raltegravir + Lopinavir/Ritonavir Versus Efavirenz + Tenofovir + Emtricitabine in Treatment Naive PatientsCompletedNCT00752856Phase 2Results posted
• BRAVO: Background Regimen of Raltegravir on Virologic OutcomeCompletedNCT00751530Results posted
• Comparing Raltegravir Genital Tract Distribution in HIV-infected Men and WomenCompletedNCT00745368Not applicableResults posted
• PMS Assessing the Long-term Efficacy and Safety of Nevirapine Therapy (Combined With Other ARV Drugs) in HIV-1 Positive Patients in Daily Clinical Practice.CompletedNCT00736502Results posted
• Maraviroc as an Immunomodulatory Drug for Antiretroviral-treated HIV Infected Patients Exhibiting Immunologic FailureCompletedNCT00735072Phase 4Results posted
• Genetic Predictors of Raltegravir Penetration Into Cerebrospinal FluidCompletedNCT00729924Phase 2/3Results posted
• A Study in Underrepresented Patient Population or Regimen Tolerability: SUPPoRTCompletedNCT00727597Phase 3Results posted
• Safety and Efficacy Study of Switching From Epzicom to TruvadaCompletedNCT00724711Phase 4Results posted
• Pharmacokinetics, Safety And Toleration Of Maraviroc Administered To Subjects With Various Degrees Of Renal Impaired And Normal Renal FunctionCompletedNCT00717067Phase 4Results posted
• Single DermaVir Immunization in HIV-1 Infected Patients on HAARTCompletedNCT00712530Phase 1Results posted
• Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL)CompletedNCT00711009Phase 3Results posted
• Impact of a Human Papilloma Virus (HPV) Vaccine in HIV-Infected Young WomenCompletedNCT00710593Phase 2Results posted
• Adding Maraviroc to Antiretroviral Therapy for Suboptimal CD4 T-Cell Recovery Despite Sustained Virologic SuppressionCompletedNCT00709111Not applicableResults posted
• Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Elvitegravir Versus RaltegravirCompletedNCT00708162Phase 3Results posted
• Phase IIa Dose-ranging Study of GSK1349572 in HIV-1 Infected AdultsCompletedNCT00708110Phase 2Results posted
• Immune Responses to Pneumococcal Vaccination Among HIV-infected SubjectsCompletedNCT00706550Not applicableResults posted
• Safety and Effectiveness of TFV 1% Gel, TDF Tablets, and FTC/TDF Tablets in Preventing HIV in WomenCompletedNCT00705679Phase 2Results posted
• Smoking Cessation Using Motivational Therapy and VareniclineCompletedNCT00701896Not applicableResults posted
• Kaletra-isentress Treatment EvaluationCompletedNCT00700115Phase 4Results posted
• Enema Use and Acceptability in HIV Negative Men Who Have Sex With MenCompletedNCT00696618Not applicableResults posted
• Vicriviroc (SCH 417690) Treatment Protocol in Human Immunodeficiency Virus (HIV)-Infected Participants: A Rollover Study for ACTG Protocol A5211 (P04100)CompletedNCT00686829Phase 2Results posted
• Qualitative Assessment of Implementing Routine Rapid HIV TestingCompletedNCT00680862Results posted
• Kaletra and Viread in Antiretroviral Naïve PatientsTerminatedNCT00679926Phase 4Results posted
• Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive ProceduresTerminatedNCT00678587Phase 3Results posted
• Aging & HIV/AIDS Neurocognitive Sequelae and Functional ConsequencesCompletedNCT00675766Results posted
• Raltegravir Augmentation on Persistent Central Nervous System (CNS) Immunoactivation in Treated HIV-1 PatientsCompletedNCT00672932Not applicableResults posted
• HIV Screening in the Emergency Department SettingCompletedNCT00667186Not applicableResults posted
• Prospective Observational Epidemiologic Study of Maraviroc's SafetyCompletedNCT00665561Results posted
• Pilot Project of Virologic and Immunologic Correlates of GALT Immune Reconstitution Following Raltegravir TherapyCompletedNCT00661960Not applicableResults posted
• China Antiretroviral Treatment Adherence for LifeCompletedNCT00661258Not applicableResults posted
• Raltegravir + Lopinavir/Ritonavir or Emtricitabine/Tenofovir for HIV Treatment Naive SubjectsCompletedNCT00654147Phase 2Results posted
• The SOLVE-IT National Randomized TrialCompletedNCT00653991Not applicableResults posted
• The Effect of Raltegravir on HIV Decay During Primary and Chronic InfectionCompletedNCT00641641Not applicableResults posted
• Efficacy of an Abstinence-Only HIV Risk-Reduction Intervention for Young African-American AdolescentsCompletedNCT00640653Not applicableResults posted
• Evaluation of the DPP HIV 1/2 Test and the HIV 1/2 Stat Pak Test Using Oral FluidCompletedNCT00636220Results posted
• Raltegravir vs. Lopinavir/Ritonavir, Both in Combination With Truvada, in HIV+ Treatment Naive IndividualsTerminatedNCT00632970Phase 4Results posted
• Raltegravir Intensification in HIV-infected PatientsCompletedNCT00631449Phase 4Results posted
• FEM-PrEP (Truvada®): Study to Assess the Role of Truvada® in Preventing HIV Acquisition in WomenCompletedNCT00625404Phase 3Results posted
• Clinical Trial of CNS-targeted HAART (CIT2)CompletedNCT00624195Phase 2/3Results posted
• A Study of Invirase (Saquinavir)/Ritonavir in HIV-Infected Infants and Children.CompletedNCT00623597Phase 2Results posted
• Pharmaco-epidemiological Description of the Population Treated With Aptivus Under Market Conditions, Safety & EfficacyCompletedNCT00615290Results posted
• MK-0518 Intensification And HDAC Inhibition In Depletion Of Resting CD4+ T Cell HIV InfectionTerminatedNCT00614458Phase 2Results posted
• Determining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected AdultsCompletedNCT00608569Not applicableResults posted
• HIV Non Occupational Post-Exposure Prophylaxis (PEP)CompletedNCT00594646Phase 4Results posted
• Adherence and Acceptability to and Blood Levels of Tenofovir Gel and Tablets in HIV Uninfected WomenCompletedNCT00592124Phase 2Results posted
• Safety and Immunogenicity of GlaxoSmithKline Biologicals' HPV Vaccine 580299 (Cervarix) in HIV Infected FemalesCompletedNCT00586339Phase 2Results posted
• Pharmacokinetic Interactions Between Buprenorphine and Kaletra (Lopinavir/Ritonavir)CompletedNCT00571961Not applicableResults posted
• VERxVE Study on Efficacy and Safety of Nevirapine XR in Comparison to Nevirapine IR With Truvada in Naive HIV+ PatientsCompletedNCT00561925Phase 3Results posted
• Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition Within HIV-1 Discordant CouplesCompletedNCT00557245Phase 3Results posted
• Nevirapine vs. Atazanavir Boosted With Ritonavir on a Background of Truvada in Human Immunodeficiency Virus (HIV) Infected Naive Patients (NEwArT)CompletedNCT00552240Phase 4Results posted
• KIVEXA Vs TRUVADA, Both Administered With Efavirenz, In ART-Naive SubjectsCompletedNCT00549198Phase 4Results posted
• Rapid HIV Testing Program in the Emergency DepartmentCompletedNCT00548041Not applicableResults posted
• Acupuncture and Relaxation Response for GI Symptoms and HIV Medication AdherenceCompletedNCT00545623Phase 2Results posted
• Observational Non-interventional Study With Viramune® in Combination With Truvada® in HIV-infected PatientsCompletedNCT00543803Results posted
• TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase InhibitorsCompletedNCT00543725Phase 3Results posted
• Efficacy Study of Substitution of Darunavir/Ritonavir (DRV/r) for Dual-boosted Protease InhibitorsCompletedNCT00543101Phase 4Results posted
• TMC278-TiDP6-C209: A Clinical Trial in Treatment Naive HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine.CompletedNCT00540449Phase 3Results posted
• Optimizing Treatment for Treatment-Experienced, HIV-Infected PeopleCompletedNCT00537394Phase 3Results posted
• Observational Non-interventional Study (Anwendungsbeobachtung) With Aptivus® (Tipranavir) in HIV-infected Patients.CompletedNCT00531206Results posted
• Tipranavir/Ritonavir Low Dose Pharmacokinetics in Treatment Naive PatientsCompletedNCT00530920Phase 2Results posted
• Evaluating the Effect of CHanging EnfuvirtidE to Raltegravir in HIV Infected SubjectsCompletedNCT00529243Phase 3Results posted
• Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected ChildrenCompletedNCT00528957Phase 3Results posted
• Standard Antiretroviral v. Multi-class Therapy in Acutely HIV-1 Infected Antiretroviral-Naïve Subjects (ADARC 2007-01)CompletedNCT00525733Not applicableResults posted
• A Study to Compare Effectiveness and Safety of Darunavir/Ritonavir (DRV/Rtv) 800mg/100mg Once Daily Versus DRV/Rtv 600mg/100mg Twice Daily in Early Treatment-Experienced HIV-1 Infected Patients (ODIN)CompletedNCT00524368Phase 3Results posted
• RAL-eve Study: Raltegravir Substitution StudyCompletedNCT00523237Not applicableResults posted
• Pilot Study of Pyridostigmine Upon Immune Activation in HIV-1 Patients Who Have an Inadequate Immune ResponseCompletedNCT00518154Phase 2Results posted
• Comparison of TPV/r to DRV/r in Triple Class Experienced Patient With Resistance to > 1 PITerminatedNCT00517192Phase 3Results posted
• Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral LoadCompletedNCT00515827Phase 2Results posted
• Autologous Dendritic Cell Vaccine in HIV1 InfectionCompletedNCT00510497Phase 1/2Results posted
• HIV Testing Strategies in the Perinatal SettingCompletedNCT00503308Not applicableResults posted
• Two Approaches to Routine HIV Testing in a Hospital Emergency DepartmentCompletedNCT00502944Not applicableResults posted
• Multicenter Pilot Study To Define The Marker As An Alternate For Tropism AssayTerminatedNCT00496782Phase 1Results posted
• Preservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/Ritonavir (ATV/r)CompletedNCT00491556Not applicableResults posted
• A Study of Fuzeon (Enfuvirtide) With an Integrase Inhibitor Plus Optimized Background in Treatment-Experienced HIV-1 Infected PatientsTerminatedNCT00488059Phase 4Results posted

← HIV Infections overview